(Q54313549)

English

A phase II study of idarubicin and prednisone in multiple myeloma.

scientific article published in October 1990

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

title

A phase II study of idarubicin and prednisone in multiple myeloma. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

author name string

A S Alberts

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

G Falkson

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

B L Rapoport

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

A Uys

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

publication date

1 October 1990

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

published in

Tumori

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

volume

76

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

page(s)

465-466

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

Identifiers

DOI

10.1177/030089169007600509

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

PubMed publication ID

2256191

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2256191

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/2256191

(Q54313549)

A phase II study of idarubicin and prednisone in multiple myeloma.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)